BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 2:50:00 PM | Browse: 1062 | Download: 1001
Publication Name World Journal of Diabetes
Manuscript ID 1685
Country United States
Received
2012-12-27 16:37
Peer-Review Started
2012-12-28 14:56
To Make the First Decision
2013-02-01 21:39
Return for Revision
2013-02-06 17:08
Revised
2013-03-20 04:18
Second Decision
2013-04-10 16:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-04-11 04:40
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-11-26 13:40
Publish the Manuscript Online
2013-12-20 16:49
ISSN 1948-9358 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Nutrition & Dietetics
Manuscript Type Topic Highlights
Article Title Ranibizumab in diabetic macular edema
Manuscript Source Invited Manuscript
All Author List Claudia Krispel, Murilo Rodrigues, Xiaoban Xin and Akrit Sodhi
Funding Agency and Grant Number
Funding Agency Grant Number
National Eye Institute, National Institutes of Health K08-EY021189
Unrestricted Grant from Research to Prevent Blindness
A Career Development Award Recipient from the Research to Prevent Blindness Foundation to Dr. Sodhiand
Scholar at the Wilmer Eye Institute to Ryan SJ
Corresponding Author Akrit Sodhi, MD, PhD, Wilmer Eye Institute, Johns Hopkins School of Medicine, 400 N Broadway Street, Smith Building 4039, Baltimore, MD 21287,United States. sodhi1@jhmi.edu
Key Words Diabetes; Macular edema; Vascular endothelial growth factor; Ranibizumab; Lucentis®; Bevacizumab; Avastin®; Intravitreal injection
Core Tip This article reviews the use of ranibizumab for diabetic macular edema. The article presents recent data on which the practice of ranibizumab injections for diabetic macular edema is based, and highlights issues regarding efficacy, safety, and other important considerations for any retina provider using ranibizumab in practice.
Publish Date 2013-12-20 16:49
Citation Krispel C, Rodrigues M, Xin X, Sodhi A. Ranibizumab in diabetic macular edema. World J Diabetes 2013; 4(6): 310-318 Available from: URL: http://www.wjgnet.com/1948-9358/full/v4/i6/310.htm DOI: http://dx.doi.org/10.4239/wjd.v4.i6.310
URL http://www.wjgnet.com/1948-9358/full/v4/i6/310.htm
DOI http://dx.doi.org/10.4239/wjd.v4.i6.310
Full Article (PDF) WJD-4-310.pdf
Full Article (Word) WJD-4-310.doc
Manuscript File 1685-Review.doc
Answering Reviewers 1685-Answering reviewers.pdf
Copyright License Agreement 1685-Copyright assignment.pdf
Peer-review Report 1685-Peer review.pdf
Scientific Editor Work List 1685-Scientific editor work list.doc